Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.19
17.07
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AALR3 stock under the Base Case scenario is 16.48 BRL. Compared to the current market price of 14.68 BRL, Centro de Imagem Diagnosticos SA is Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Centro de Imagem Diagnosticos SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AALR3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Centro de Imagem Diagnosticos SA
Balance Sheet Decomposition
Centro de Imagem Diagnosticos SA
Current Assets | 563.8m |
Cash & Short-Term Investments | 209.9m |
Receivables | 272.5m |
Other Current Assets | 81.4m |
Non-Current Assets | 2.1B |
Long-Term Investments | 49.2m |
PP&E | 788.8m |
Intangibles | 1B |
Other Non-Current Assets | 287m |
Current Liabilities | 719.2m |
Accounts Payable | 140.2m |
Accrued Liabilities | 257.8m |
Other Current Liabilities | 321.3m |
Non-Current Liabilities | 884.1m |
Long-Term Debt | 785.5m |
Other Non-Current Liabilities | 98.6m |
Earnings Waterfall
Centro de Imagem Diagnosticos SA
Revenue
|
1.2B
BRL
|
Cost of Revenue
|
-834.7m
BRL
|
Gross Profit
|
354.3m
BRL
|
Operating Expenses
|
-316.4m
BRL
|
Operating Income
|
37.9m
BRL
|
Other Expenses
|
-256.3m
BRL
|
Net Income
|
-218.4m
BRL
|
Free Cash Flow Analysis
Centro de Imagem Diagnosticos SA
BRL | |
Free Cash Flow | BRL |
Allianca marked a pivotal Q2 2024 by reporting its first net profit in nearly three years, a testament to successful recovery strategies. The company achieved record quarterly gross revenue of BRL 338 million, growing 5% year-over-year. Cost reductions and growth in B2B partnerships fueled the highest adjusted EBITDA in history at BRL 85 million. Imaging exam productivity hit a historic average, reflecting strategic asset optimization. The EBITDA margin soared to 27%, and net debt leverage declined to 2.7x. Allianca's future focuses on expanding revenue through partnerships, optimizing resources, and maintaining financial discipline, positioning the company for sustained growth.
What is Earnings Call?
AALR3 Profitability Score
Profitability Due Diligence
Centro de Imagem Diagnosticos SA's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Centro de Imagem Diagnosticos SA's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
AALR3 Solvency Score
Solvency Due Diligence
Centro de Imagem Diagnosticos SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Centro de Imagem Diagnosticos SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AALR3 Price Targets Summary
Centro de Imagem Diagnosticos SA
According to Wall Street analysts, the average 1-year price target for AALR3 is 20.91 BRL with a low forecast of 20.71 BRL and a high forecast of 21.53 BRL.
Dividends
Current shareholder yield for AALR3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Centro de Imagem Diagnósticos SA is a holding company, which engages in the provision of medical diagnostic services. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2016-10-28. The firm focuses on managing medical and diagnostic laboratories. The firm offers medical and diagnostic imaging services, such as biopsy, bone densitometry, laboratory tests, digital mammography, Doppler echocardiography, positron emission tomography (PET) scan for oncology, X-radiation (X-rays), magnetic resonance imaging (MRI), computer tomography (CT), prenatal tests and ultrasounds. The firm operates a number of units in the states of Parana, Para, Minas Gerais, Bahia, Espirito Santo, Rio de Janeiro, Rio Grande do Norte and Sao Paulo, among others, Brazil.
Contact
IPO
Employees
Officers
The intrinsic value of one AALR3 stock under the Base Case scenario is 16.48 BRL.
Compared to the current market price of 14.68 BRL, Centro de Imagem Diagnosticos SA is Undervalued by 11%.